These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30953607)

  • 1. Lithium counteracts depressive behavior and augments the treatment effect of selective serotonin reuptake inhibitor in treatment-resistant depressed rats.
    Kin K; Yasuhara T; Kawauchi S; Kameda M; Hosomoto K; Tomita Y; Umakoshi M; Kuwahara K; Kin I; Kidani N; Morimoto J; Sasaki T; Date I
    Brain Res; 2019 Aug; 1717():52-59. PubMed ID: 30953607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine attenuates stress-induced depressive-like behavior through modulation of hippocampal GAP43 and neurogenesis in male rats.
    Zavvari F; Nahavandi A; Goudarzi M
    J Chem Neuroanat; 2020 Jan; 103():101711. PubMed ID: 31705954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine effects on behavior and adult hippocampal neurogenesis in female C57BL/6J mice across the estrous cycle.
    Yohn CN; Shifman S; Garino A; Diethorn E; Bokka L; Ashamalla SA; Samuels BA
    Psychopharmacology (Berl); 2020 May; 237(5):1281-1290. PubMed ID: 31965254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial resistance to citalopram in a Wistar-Kyoto rat model of depression: An evaluation using resting-state functional MRI and graph analysis.
    Li Q; Zhao W; Liu S; Zhao Y; Pan W; Wang X; Liu Z; Xu Y
    J Psychiatr Res; 2022 Jul; 151():242-251. PubMed ID: 35500452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison between Sprague-Dawley rats and the Wistar-Kyoto rat model of depression.
    Millard SJ; Lum JS; Fernandez F; Weston-Green K; Newell KA
    J Psychopharmacol; 2019 Feb; 33(2):230-243. PubMed ID: 30698051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats.
    Griebel G; Cohen C; Perrault G; Sanger DJ
    Physiol Behav; 1999 Sep; 67(3):315-20. PubMed ID: 10497947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence.
    Rayen I; van den Hove DL; Prickaerts J; Steinbusch HW; Pawluski JL
    PLoS One; 2011; 6(9):e24003. PubMed ID: 21912658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice.
    Vijaya Kumar K; Rudra A; Sreedhara MV; Siva Subramani T; Prasad DS; Das ML; Murugesan S; Yadav R; Trivedi RK; Louis JV; Li YW; Bristow LJ; Naidu PS; Vikramadithyan RK
    Brain Behav Immun; 2014 Nov; 42():204-11. PubMed ID: 25016199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS inhibits the effects of fluoxetine on depression-like behavior and hippocampal neurogenesis in rats.
    Wang Y; Cui XL; Liu YF; Gao F; Wei D; Li XW; Wang HN; Tan QR; Jiang W
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1831-5. PubMed ID: 21791234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
    Rogóż Z; Kabziński M; Sadaj W; Rachwalska P; Gądek-Michalska A
    Pharmacol Rep; 2012; 64(6):1391-9. PubMed ID: 23406749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel 5HT3 receptor-IGF1 mechanism distinct from SSRI-induced antidepressant effects.
    Kondo M; Koyama Y; Nakamura Y; Shimada S
    Mol Psychiatry; 2018 Apr; 23(4):833-842. PubMed ID: 28439104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats.
    Tizabi Y; Hauser SR; Tyler KY; Getachew B; Madani R; Sharma Y; Manaye KF
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):62-9. PubMed ID: 19800382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin receptor deficiency confers resistance to behavioral effects of fluoxetine and desipramine via separable substrates.
    Guo M; Lu XY
    Transl Psychiatry; 2014 Dec; 4(12):e486. PubMed ID: 25463972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of perinatal fluoxetine exposure on emotionality behaviours and cortical and hippocampal glutamatergic receptors in female Sprague-Dawley and Wistar-Kyoto rats.
    Millard SJ; Lum JS; Fernandez F; Weston-Green K; Newell KA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110174. PubMed ID: 33189859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants.
    Getachew B; Hauser SR; Csoka AB; Taylor RE; Tizabi Y
    Drug Alcohol Depend; 2017 Jun; 175():133-139. PubMed ID: 28414989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants.
    Will CC; Aird F; Redei EE
    Mol Psychiatry; 2003 Nov; 8(11):925-32. PubMed ID: 14593430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
    du Jardin KG; Liebenberg N; Müller HK; Elfving B; Sanchez C; Wegener G
    Psychopharmacology (Berl); 2016 Jul; 233(14):2813-25. PubMed ID: 27236785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of New Approaches to Depression Treatment Using an Animal Model of Pharmacoresistant Depression.
    Zvozilova A; Bukatova S; Koprdova R; Mach M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences.
    Millard SJ; Weston-Green K; Newell KA
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109908. PubMed ID: 32145362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.